In late July, Charlie Gard, the baby stricken with the rare and typically fatal genetic disorder known as Mitochondrial DNA Depletion Syndrome, died. Charlie was at the center of a legal battle between his parents and the British healthcare system … Continue reading
It’s every parent’s nightmare. Your child is suffering and you are powerless to do anything about it. In most cases you would exhaust all treatment options, consult leading specialists, and even travel the globe to find a hospital for your … Continue reading
In a recent television interview, Aetna CEO Mark Bertolini, head of one of America’s largest health insurers, commented that selling insurance across state lines is “an outdated concept” in the discussion of healthcare reform. Bertolini went on to explain the … Continue reading
“Repeal” and “replace” are the new buzzwords, with no signs of being bumped from the headlines anytime soon. Since the 2016 election, the Affordable Care Act (ACA) has been in the crosshairs of the Republican-controlled Congress and Donald Trump. The … Continue reading
It’s that time of year again. Time for vibrant fall colors, cool crisp morning air, and open enrollment in the Affordable Care Act (ACA) insurance exchanges—the government-regulated, state-based healthcare plans set up as part of the act. Since the ACA’s … Continue reading
For those who may be unfamiliar with the players in the pharmaceutical business, Mylan is a successful, mid-sized manufacturer of branded and generic drugs. One of their largest products is the EpiPen, which is an auto-injection device used to treat … Continue reading
